Neurogene Inc.
NGNE
$15.00
$1.9715.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -4,666.56% | -67.23% | -77.66% | -87.37% | -95.89% |
| Gross Profit | 4,769.68% | 69.37% | 79.84% | 87.37% | 95.89% |
| SG&A Expenses | 102.10% | 79.30% | 82.52% | 49.88% | 26.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 50.28% | 42.48% | 35.11% | 12.55% | -1.88% |
| Operating Income | -48.62% | -40.76% | -33.32% | -12.55% | 1.88% |
| Income Before Tax | -106.91% | -4.50% | 2.70% | 21.67% | 34.26% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -106.91% | -4.50% | 2.70% | 21.67% | 34.26% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.91% | -4.50% | 2.70% | 21.67% | 34.26% |
| EBIT | -48.62% | -40.76% | -33.32% | -12.55% | 1.88% |
| EBITDA | -51.78% | -43.68% | -35.71% | -13.28% | 2.17% |
| EPS Basic | 30.90% | 187.02% | 178.44% | 158.90% | 41.03% |
| Normalized Basic EPS | 96.08% | 72.15% | 5.06% | -129.37% | -939.46% |
| EPS Diluted | 94.93% | 99.71% | 46.66% | -60.20% | -704.16% |
| Normalized Diluted EPS | 95.15% | 95.45% | 40.23% | -70.90% | -740.59% |
| Average Basic Shares Outstanding | 3,471.62% | 635.91% | 194.76% | 11.53% | -90.69% |
| Average Diluted Shares Outstanding | 277.22% | 874.25% | 335.33% | 112.31% | -11.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |